underwritten

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public OfferingNexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) --  Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in…

1 week ago
Rezolute, Inc. Announces Closing of Underwritten OfferingRezolute, Inc. Announces Closing of Underwritten Offering

Rezolute, Inc. Announces Closing of Underwritten Offering

April 25, 2025 16:30 ET  | Source: Rezolute, Inc. NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq:…

3 weeks ago
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common StockMineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock

Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock

March 11, 2025 22:20 ET  | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…

2 months ago
Neuronetics Announces Launch of Underwritten Public Offering of Common StockNeuronetics Announces Launch of Underwritten Public Offering of Common Stock

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

February 06, 2025 16:23 ET  | Source: Neuronetics MALVERN, Pa., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM)…

3 months ago
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public OfferingAEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

January 06, 2025 09:00 ET  | Source: AEON Biopharma IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc.…

4 months ago
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public OfferingAEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

January 06, 2025 09:00 ET  | Source: AEON Biopharma IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc.…

4 months ago